Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-19

FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the Original Application for Amoxicillin and clavulanate potassium from Aurobindo Pharma Limited, a generic antibiotic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN AND CLAVULANATE POTASSIUM (amoxicillin and clavulanate potassium)

Snippet

ORIG AP for AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN AND CLAVULANATE POTASSIUM)